Antibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN966365 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Nuclear Factor of kappa Light Polypeptide Gene Enhancer in B-Cells Inhibitor, alpha (NFKBIA) antibody
- Antibody type
- Polyclonal
- Antigen
- The antiserum was produced against synthesized non-phosphopeptide derived from human IB- around the phosphorylation site of serine 32/36 (H-D-SP-G-L- D-SP -M-K).
- Description
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Vial size
- 100 μg
- Concentration
- 100ug/100ul
- Storage
- -20°C
Submitted references Transient and selective NF-kappa B p65 serine 536 phosphorylation induced by T cell costimulation is mediated by I kappa B kinase beta and controls the kinetics of p65 nuclear import.
A hypermorphic IkappaBalpha mutation is associated with autosomal dominant anhidrotic ectodermal dysplasia and T cell immunodeficiency.
NF-kappaB is constitutively activated in high-grade squamous intraepithelial lesions and squamous cell carcinomas of the human uterine cervix.
A novel mechanism for the inhibition of NF-kappaB activation in vascular endothelial cells by natural antioxidants.
Temporal pattern of NFkappaB activation influences apoptotic cell fate in a stimuli-dependent fashion.
Mattioli I, Sebald A, Bucher C, Charles RP, Nakano H, Doi T, Kracht M, Schmitz ML
Journal of immunology (Baltimore, Md. : 1950) 2004 May 15;172(10):6336-44
Journal of immunology (Baltimore, Md. : 1950) 2004 May 15;172(10):6336-44
A hypermorphic IkappaBalpha mutation is associated with autosomal dominant anhidrotic ectodermal dysplasia and T cell immunodeficiency.
Courtois G, Smahi A, Reichenbach J, Döffinger R, Cancrini C, Bonnet M, Puel A, Chable-Bessia C, Yamaoka S, Feinberg J, Dupuis-Girod S, Bodemer C, Livadiotti S, Novelli F, Rossi P, Fischer A, Israël A, Munnich A, Le Deist F, Casanova JL
The Journal of clinical investigation 2003 Oct;112(7):1108-15
The Journal of clinical investigation 2003 Oct;112(7):1108-15
NF-kappaB is constitutively activated in high-grade squamous intraepithelial lesions and squamous cell carcinomas of the human uterine cervix.
Nair A, Venkatraman M, Maliekal TT, Nair B, Karunagaran D
Oncogene 2003 Jan 9;22(1):50-8
Oncogene 2003 Jan 9;22(1):50-8
A novel mechanism for the inhibition of NF-kappaB activation in vascular endothelial cells by natural antioxidants.
Schubert SY, Neeman I, Resnick N
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2002 Dec;16(14):1931-3
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2002 Dec;16(14):1931-3
Temporal pattern of NFkappaB activation influences apoptotic cell fate in a stimuli-dependent fashion.
Fan C, Yang J, Engelhardt JF
Journal of cell science 2002 Dec 15;115(Pt 24):4843-53
Journal of cell science 2002 Dec 15;115(Pt 24):4843-53
No comments: Submit comment
No validations: Submit validation data